in ,

Battelle, Astrotech Subsidiary Advance to Chemical Detector Program’s 2nd Phase

https://executivebiz-media.s3.amazonaws.com/2022/08/19/30/9f/c3/a0/b7/6f/d4/64/Executive-Biz.png

BiohazardBattelle and its Astrotech subsidiary partner will continue their collaboration in developing a portable mass spectrometer onto the second phase of the U.S. military’s three-phase Next Generation Chemical Detector program.

Astrotech said Tuesday Battelle and 1st Detect Corp. will move forward to testing and evaluation of the latter’s prototype Multi-Sample Identifier Detector.

“We are working in close collaboration with our key partner Battelle to validate and refine our joint detection solution,” said Astrotech CEO Thomas Pickens III.

The Multi-Sample Identifier Detector technology will work to support the chemical detection and analysis market through applications in the healthcare, process flow, security, research and industrial sectors, Astrotech added.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Products & Service

mm

Written by Anna Forrester

MDA Lands Ground Station Support, Training Contract with Malaysian Agency
BAE Opens Maintenance Hub for Saudi Arabia’s Typhoon Fighter Planes